DrugDashboards

Lidocaine and prilocaine

Lidocaine and prilocaine · LIDOCAINE 25 mg/g; PRILOCAINE 25 mg/g · Cream · Topical · Viona Pharmaceuticals Inc

NDC 72578-0165-06 · 1 TUBE in 1 CARTON / 30 g in 1 TUBE · ANDA · View full market →

The short version

13 companies supply this market — deep enough that no single failure threatens the supply. The price is down 18% over the past year, to $0.2211 per gram. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00574-2042-30) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$0.3837per unit
middle half $0.2770$0.4472 · 5,474 plans · Apr 1, 2026
Est. net of rebates
≈ $0.3837
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 3 · prior auth 27% · step therapy 0% · qty limit 62%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

$0$0.1$0.2$0.3Jun 2025Sep 2026$0.2211
16 price points · per GMSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$15.00
Reported to Texas DSHS · 2026 annual filing · Viona Pharmaceuticals Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$157,130
10,831 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for lidocaine and prilocaine (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA219120
TE code
AB
Approval date
Dec 17, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lidocaine and prilocaine (Cream)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackLIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 3, 2026
Preferred Pharmaceuticals Inc.LIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 3, 2026
A-S Medication SolutionsLIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.LIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedLIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026
E. Fougera & Co. a division of Fougera Pharmaceuticals, LLCLIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026
Encube Ethicals, Inc.LIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026
NuCare Pharamceuticals,Inc.LIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals, Inc.LIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026
Padagis US LLCLIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026
PAI Holdings, LLC dba PAI PharmaLIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026
Viona Pharmaceuticals IncLIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedLIDOCAINE 25 mg/g; PRILOCAINE 25 mg/gJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lidocaine and prilocaine — NDC 72578-0165-06," retrieved September 3, 2026, https://drugdashboards.com/drug/72578016506.

Free to cite with attribution — see how the data is put together.